Lykan Bioscience - Now RoslinCT Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

RoslinCT operates as a global contract development and manufacturing organization focused on advanced cell and gene therapies, offering development, analytical, and cGMP manufacturing capabilities to support moving therapies from development to commercialization. Its heritage dates to 2006 and draws on the Roslin Institute's pioneering cloning work from the late 1990s, exemplified by milestones in clinical-grade human pluripotent stem cells and CRISPR-edited cell therapy progress. The company maintains 22 cGMP cell therapy processing suites across two sites—Edinburgh, Scotland, and Hopkinton, Massachusetts—serving both autologous and allogeneic programs and including iPSC line development, gene editing, and differentiation.

RoslinCT's services are oriented toward biotech partners seeking seamless progression from development through manufacturing to commercialization of cell and gene therapies. Based in Hopkinton, Massachusetts, the company operates in a global landscape and recently announced an expansion of its Hopkinton site to add cleanroom space for products spanning autologous and allogeneic therapies.

Sign up for free to view info

Company overview Email format